The Safety, Tolerability, and Pharmacokinetics of of SYH9017 in Chinese Participants With Overweight and Obesity

Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
This is a randomized, double-blind, single-center, dose-escalation, single ascending dose and multiple ascending dose study of SYH9017 in Chinese participants with overweight and obesity.
Epistemonikos ID: bec6ff172015d7bdabf37989743140421fccbf73
First added on: Mar 01, 2025